Innovation, Partnerships and Market Access in One of the World’s Leading Life Sciences Market
This web-seminar is part of our international “Biotech Goes Global” series, supporting Bavarian biotech companies in accessing key global markets.
This edition puts the spotlight on Japan – one of the world’s largest pharmaceutical markets, characterised by a highly innovative research landscape, strong government support for healthcare innovation, and growing opportunities for international collaboration in biotechnology, pharmaceuticals, medical technology, and regenerative medicine.
Join us to explore how Bavarian and European life sciences companies can strategically engage with Japan’s innovation ecosystem, identify relevant partnership opportunities, and better understand the support structures available for entering and growing in the Japanese market.
This session addresses key considerations for companies in the health sector, including biotechnology, pharmaceuticals, medical technology, and digital health, that are interested in gaining a better understanding of Japan’s life sciences landscape.
The webinar combines perspectives on the Japanese innovation ecosystem with practical guidance on market entry, funding opportunities, and regulatory support. It is particularly valuable for companies considering expansion into Japan, seeking local partners, or exploring participation in major industry events such as BioJapan and other Japan-focused partnering activities.
In this session, you will:
- gain insights into Japan’s life sciences ecosystem, key innovation hubs, and emerging research and technology strengths
- learn about collaboration opportunities and support structures available to international companies entering the Japanese market
- discover funding and soft-landing initiatives such as JETRO’s Japan Entry Acceleration Program (JEAP) and other programmes designed to facilitate cross-border collaboration and business development
- receive practical guidance on regulatory pathways, market access, and commercialisation support available through organisations such as HekaBio and MediSo for healthcare innovators entering Japan
Agenda:
9:00 Welcome & Context (BioM) – 5min
9:05 Why Japan? (MediSo) – 15min
9:20 Programmes for International Companies:JEAP (JETRO) -15min
9:35 From Market Entry to Market Success (HekaBio) – 15min
9:50 Moderated Discussion and Q&A – 10min
Speakers:
Rodeny Kelley, HekaBio
Sumire Saito, Project Manager, JETRO
